Trials / Completed
CompletedNCT00416845
Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers
A Randomized, Parallel Group, Double-blind, Placebo Controlled, 14 Days Multiple-dose Treatment to Assess the Pulmonary and Cardiac Pharmacodynamics of FTY720 (0.5 and 1.25 mg) in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to assess the effects of two doses of FTY720 on lung (pulmonary) and cardiac (heart) functions in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FTY720 |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-03-01
- First posted
- 2006-12-28
- Last updated
- 2010-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00416845. Inclusion in this directory is not an endorsement.